Hepatitis Monthly

Published by: Kowsar

Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes

Fahime Bahri 1 , Ali Kargar Kheirabad 2 , Iman Ghasemzadeh 3 , Saeed Shoja 3 and Hamed Gouklani 4 , *
Authors Information
1 Department of Microbiology, Jahrom Branch, Islamic Azad University, Jahrom, IR Iran
2 Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, IR Iran
3 Infectious and Tropical Disease Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran
4 Molecular Medicine Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, IR Iran
Article information
  • Hepatitis Monthly: January 01, 2016, 16 (1); e32971
  • Published Online: January 23, 2016
  • Article Type: Research Article
  • Received: September 6, 2015
  • Accepted: December 19, 2015
  • DOI: 10.5812/hepatmon.32971

To Cite: Bahri F, Kargar Kheirabad A, Ghasemzadeh I, Shoja S, Gouklani H. Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes, Hepat Mon. 2016 ; 16(1):e32971. doi: 10.5812/hepatmon.32971.

Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Dodd RY. Current viral risks of blood and blood products. Ann Med. 2000; 32(7): 469-74[PubMed]
  • 2. Chow KM, Szeto CC, Wu AK, Leung CB, Kwan BC, Li PK. Continuous ambulatory peritoneal dialysis in patients with hepatitis B liver disease. Perit Dial Int. 2006; 26(2): 213-7[PubMed]
  • 3. Mayhall CG. Hospital epidemiology and infection control. 2012;
  • 4. Pérez ER. Catheter-Related Bloodstream Infections in Critical Care. 2012;
  • 5. Mashragi F, Bernstein RS, Al-Mazroa M, Al-Tawfiq JA, Filemban S, Assiri A, et al. HIV transmission at a Saudi Arabia hemodialysis unit. Clin Infect Dis. 2014; 59(6): 897-902[DOI][PubMed]
  • 6. Su Y, Yan R, Duan Z, Norris JL, Wang L, Jiang Y, et al. Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China. J Med Virol. 2013; 85(3): 425-32[DOI][PubMed]
  • 7. Mohammed AA, Enan KA, Khair OM, Hussien MO, El Hussein ARM, Elkhidir IM. Prevalence of occult hepatitis B virus (HBV) infections in haemodialysis patients in Khartoum State, Sudan from 2012 to 2014. J Med Lab Diagn. 2015; 6(4): 22-6
  • 8. Abu El Makarem MA, Abdel Hamid M, Abdel Aleem A, Ali A, Shatat M, Sayed D, et al. Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection. Hepat Mon. 2012; 12(4): 253-8[DOI][PubMed]
  • 9. Palanisamy S, Patil SB, Baskaran K, Narayana HS. Prevalence of HCV, HBV and HIV infections in patients and staff of haemodialysis unit. BMC Infect Dis. 2012; 12
  • 10. Mittal G, Gupta P, Thakuria B, Mukhiya GK, Mittal M. Profile of hepatitis B virus, hepatitis C virus, hepatitis d virus and human immunodeficiency virus infections in hemodialysis patients of a tertiary care hospital in uttarakhand. J Clin Exp Hepatol. 2013; 3(1): 24-8[DOI][PubMed]
  • 11. Gomes-Gouvea MS, Pereira Soares Mdo C, Guedes de Carvalho Mello IM, Brito EM, Pereira Moia Lde J, Bensabath G, et al. Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin. Acta Trop. 2008; 106(3): 149-55[DOI][PubMed]
  • 12. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine. 2005; 23(19): 2409-23[DOI][PubMed]
  • 13. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006; 20(16)-23[DOI][PubMed]
  • 14. Arien KK, Abraha A, Quinones-Mateu ME, Kestens L, Vanham G, Arts EJ. The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates. J Virol. 2005; 79(14): 8979-90[DOI][PubMed]
  • 15. Asim M, Singla R, Gupta RK, Kar P. Clinical & molecular characterization of human TT virus in different liver diseases. Indian J Med Res. 2010; 131: 545-54[PubMed]
  • 16. Lindh M, Gonzalez JE, Norkrans G, Horal P. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods. 1998; 72(2): 163-74[PubMed]
  • 17. Cotrina M, Buti M, Jardi R, Quer J, Rodriguez F, Pascual C, et al. Hepatitis delta genotypes in chronic delta infection in the northeast of Spain (Catalonia). J Hepatol. 1998; 28(6): 971-7[PubMed]
  • 18. Steegen K, Demecheleer E, De Cabooter N, Nges D, Temmerman M, Ndumbe P, et al. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance. J Virol Methods. 2006; 133(2): 137-45[DOI][PubMed]
  • 19. Zahedi MJ, Darvish Moghaddam S, Alavian SM, Dalili M. Seroprevalence of Hepatitis Viruses B, C, D and HIV Infection Among Hemodialysis Patients in Kerman Province, South-East Iran. Hepat Mon. 2012; 12(5): 339-43[DOI][PubMed]
  • 20. Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M, Foroughi M, et al. Frequency and Genotype of Hepatitis D Virus Infection in Patients Infected with HIV and Those Undergoing Hemodialysis. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 21. Alavian SM, Bagheri-Lankarani K, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008; 12(3): 378-82[DOI][PubMed]
  • 22. Mostaghni AA, Soltanian A, Mokhtari E, Japoni S, Mehrabani D. Seroprevalence of hepatitis B virus among hemodialysis patients in Bushehr province, southern Iran: HBV seroprevalence in hemodialysis patients. Hepat Mon. 2011; 11(3): 200-2[PubMed]
  • 23. Johnson DW, Dent H, Yao Q, Tranaeus A, Huang CC, Han DS, et al. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrol Dial Transplant. 2009; 24(5): 1598-603[DOI][PubMed]
  • 24. Otedo AE, Mc'Ligeyo SO, Okoth FA, Kayima JK. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J. 2003; 93(5): 380-4[PubMed]
  • 25. Kew MC. Hepatitis B virus / human immunodeficiency virus co-infection and its hepatocarcinogenic potential in sub-saharan black africans. Hepat Mon. 2012; 12(10 hcc)[DOI][PubMed]
  • 26. Gasim GI, Hamdan HZ, Hamdan SZ, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan. J Med Virol. 2012; 84(1): 52-5[DOI][PubMed]
  • 27. Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, et al. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Mem Inst Oswaldo Cruz. 2003; 98(5): 599-603[PubMed]
  • 28. Ferreira RC, Teles SA, Dias MA, Tavares VR, Silva SA, Gomes SA, et al. Hepatitis B virus infection profile in hemodialysis patients in Central Brazil: prevalence, risk factors, and genotypes. Mem Inst Oswaldo Cruz. 2006; 101(6): 689-92[PubMed]
  • 29. Alashek WA, McIntyre CW, Taal MW. Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infect Dis. 2012; 12: 265[DOI][PubMed]
  • 30. Alashek WA, McIntyre CW, Taal MW. Determinants of survival in patients receiving dialysis in Libya. Hemodial Int. 2013; 17(2): 249-55[DOI][PubMed]
  • 31. Neisi N, Makvandi M, Samarbaf-Zadeh AR. A study on genotypes of hepatitis B virus among hemodialysis patients in Khuzestan province. Jundishapur J Microbiol. 2011; 4(2): 65-70
  • 32. Amini-Bavil-Olyaee S, Sarrami-Forooshani R, Mahboudi F, Sabahi F, Adeli A, Noorinayer B, et al. Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients. J Med Virol. 2005; 75(2): 227-34[DOI][PubMed]
  • 33. Taghavi SA, Tabibi M, Eshraghian A, Keyvani H, Eshraghian H. Prevalence and clinical significance of hepatitis B Basal core promoter and precore gene mutations in southern Iranian patients. Hepat Mon. 2010; 10(4): 294-7[PubMed]
  • 34. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology. 1995; 38(1-2): 24-34[PubMed]
  • 35. Pivert A, Servant-Delmas A, Lunel-Fabiani F, Le Guillou-Guillemette H, Laperche S, Ducancelle A. Correlation between the promoter basal core and precore mutations and HBsAg quantification in French blood donors infected with hepatitis B virus. J Med Virol. 2015; 87(3): 529-35[DOI][PubMed]
  • 36. Norder H, Hammas B, Lee SD, Bile K, Courouce AM, Mushahwar IK, et al. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol. 1993; 74 ( Pt 7): 1341-8[DOI][PubMed]
  • 37. Kidd-Ljunggren K, Miyakawa Y, Kidd AH. Genetic variability in hepatitis B viruses. J Gen Virol. 2002; 83: 1267-80[DOI][PubMed]
  • 38. Burdick RA, Bragg-Gresham JL, Woods JD, Hedderwick SA, Kurokawa K, Combe C, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003; 63(6): 2222-9[DOI][PubMed]
  • 39. Rosenberg SD, Goodman LA, Osher FC, Swartz MS, Essock SM, Butterfield MI, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health. 2001; 91(1): 31-7[PubMed]
  • 40. El-Ottol AEKY, Elmanama AA, Ayesh BM. Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine. Virol J. 2010; 7: 210[DOI][PubMed]
  • 41. Vladutiu DS, Cosa A, Neamtu A, State D, Braila M, Gherman M, et al. Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map? J Viral Hepat. 2000; 7(4): 313-9[PubMed]
  • 42. Mahdavimazdeh M, Hosseini-Moghaddam SM, Alavian SM, Yahyazadeh H. Hepatitis B Infection in hemodialysis patients in Tehran province, Iran. Hepat Mon. 2009; 9(3): 206-10
  • 43. Sartor C, Brunet P, Simon S, Tamalet C, Berland Y, Drancourt M. Transmission of hepatitis C virus between hemodialysis patients sharing the same machine. Infect Control Hosp Epidemiol. 2004; 25(7): 609-11[DOI][PubMed]
  • 44. Hashemi B, Mahdavi-Mazdeh M, Abbasi M, Hosseini-Moghaddam SM, Zinat NH, Ahmadi F. Efficacy of HBV vaccination in various stages of chronic kidney disease: is earlier better? Hepat Mon. 2011; 11(10): 816-20[DOI][PubMed]
  • 45. Jadoul M, Goubau P. Is anti-hepatitis B virus (HBV) immunization successful in elderly hemodialysis (HD) patients? Clin Nephrol. 2002; 58(4): 301-4[PubMed]
  • 46. Hussain M, Chu CJ, Sablon E, Lok AS. Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants. J Clin Microbiol. 2003; 41(8): 3699-705[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments